ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Omega Therapeutics Inc

Omega Therapeutics Inc (OMGA)

0.1426
0.00
(0.00%)
At close: April 28 3:00PM
0.1426
0.00
( 0.00% )

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.1426
Bid
0.1111
Ask
0.1158
Volume
-
0.00 Day's Range 0.00
0.0953 52 Week Range 3.00
Market Cap
Previous Close
0.1426
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
8,834,838
Shares Outstanding
55,366,213
Dividend Yield
-
PE Ratio
-0.08
Earnings Per Share (EPS)
-1.76
Revenue
3.09M
Net Profit
-97.43M

About Omega Therapeutics Inc

Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to trans... Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to transform the practice of human medicine through highly selective and direct control of the human genome to treat and cure disease. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Omega Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker OMGA. The last closing price for Omega Therapeutics was US$0.14. Over the last year, Omega Therapeutics shares have traded in a share price range of US$ 0.0953 to US$ 3.00.

Omega Therapeutics currently has 55,366,213 shares outstanding. The market capitalization of Omega Therapeutics is US$7.90 million. Omega Therapeutics has a price to earnings ratio (PE ratio) of -0.08.

OMGA Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.14260.14260.142600CS
4000.14260.14260.142600CS
12-0.3228-69.35969058870.46540.50.095388348380.19644187CS
26-1.2274-89.59124087591.371.410.095343932830.22387269CS
52-2.1474-93.77292576422.2930.095323513250.34344676CS
156-3.6674-96.25721784783.8111.980.095310410991.45115552CS
260-21.9574-99.354751131222.131.410.09538566691.80609194CS

OMGA - Frequently Asked Questions (FAQ)

What is the current Omega Therapeutics share price?
The current share price of Omega Therapeutics is US$ 0.1426
How many Omega Therapeutics shares are in issue?
Omega Therapeutics has 55,366,213 shares in issue
What is the market cap of Omega Therapeutics?
The market capitalisation of Omega Therapeutics is USD 7.9M
What is the 1 year trading range for Omega Therapeutics share price?
Omega Therapeutics has traded in the range of US$ 0.0953 to US$ 3.00 during the past year
What is the PE ratio of Omega Therapeutics?
The price to earnings ratio of Omega Therapeutics is -0.08
What is the cash to sales ratio of Omega Therapeutics?
The cash to sales ratio of Omega Therapeutics is 2.5
What is the reporting currency for Omega Therapeutics?
Omega Therapeutics reports financial results in USD
What is the latest annual turnover for Omega Therapeutics?
The latest annual turnover of Omega Therapeutics is USD 3.09M
What is the latest annual profit for Omega Therapeutics?
The latest annual profit of Omega Therapeutics is USD -97.43M
What is the registered address of Omega Therapeutics?
The registered address for Omega Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Omega Therapeutics website address?
The website address for Omega Therapeutics is www.omegatherapeutics.com
Which industry sector does Omega Therapeutics operate in?
Omega Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TVGNTevogen Bio Holdings Inc
US$ 1.26
(34.41%)
6.15M
PTPIPetros Pharmaceuticals Inc
US$ 0.0752
(29.88%)
22.31M
AGMHAGM Group Holdings Inc
US$ 0.174
(29.85%)
91.18M
BONBon Natural Life Ltd
US$ 0.0823
(26.62%)
12.11M
WLDSWearable Devices Ltd
US$ 1.50
(25.00%)
115.41k
IXHLIncannex Healthcare Ltd
US$ 0.2199
(-63.95%)
1.07M
PITAHeramba Electric PLC
US$ 0.133
(-42.99%)
382k
PTLEPTL Ltd
US$ 1.14
(-16.18%)
2.42M
UPCUniverse Pharmaceuticals Inc
US$ 5.06
(-14.96%)
342.63k
WWWW International Inc
US$ 0.354
(-14.39%)
3.98M
AGMHAGM Group Holdings Inc
US$ 0.174
(29.85%)
91.18M
LGMKLogicMark Inc
US$ 0.0139
(7.75%)
27.59M
PTPIPetros Pharmaceuticals Inc
US$ 0.0752
(29.88%)
22.31M
DMNDamon Inc
US$ 0.0038
(0.00%)
18.87M
GNLNGreenlane Holdings Inc
US$ 0.0123
(2.50%)
16.86M

Discussion

View Full Feed
Whalatane Whalatane 1 minute ago
Well the $7 target is HC Wainwright ...so take with a cup of salt .
IMHO OLC will be approved and will easily find a market . Currently many are taking Fosrenol ...which are large pills that have to be crushed and taken with apple sauce . OLC is a new version of Fosrenol ( a " condensed ' v
UNCY
manibiotech manibiotech 2 minutes ago
I think poster meant NAS applications not the established medication applications . But I don't what the reality is . May have to listen to the video again . 
NWBO
luckydude777 luckydude777 3 minutes ago
WOK looking spunky
hardlesson hardlesson 3 minutes ago
I'd speculate that Coastar doesn't trust Sohm management's experience or abilities in this case, so they want to be in total control of the funding parameters/decisions because they know that Aguilar is way behind on being compensated for his "IP" and they know that Sohm has lots of Creditors in the
SHMN
JoeForkeyBolo JoeForkeyBolo 3 minutes ago
NEWS: Novavax Board of Directors Appreciates the Formal Support and Strategic Guidance of Shah Capital

April 28, 2025

Through constructive engagement with Shah Capital, a holder of approximately 7% of Novavax shares and who has pledged support for our Board of Director
NVAX
buysellrepeat buysellrepeat 4 minutes ago
All that volume for nothing. 
ATWT
northam43 northam43 4 minutes ago
SPX Weekly Chart.

https://investorshub.advfn.com/uimage/uploads/2025/4/28/owvos1.1_Updates.PNG

https://investorshub.advfn.com/uimage/uploads/2025/4/28/nblynWeekly_Chart.png
k9narc k9narc 4 minutes ago
"To me, stupid was thinking"....

Yep, you probably should stop doing that. You might hurt yourself.

https://investorshub.advfn.com/uimage/uploads/2025/4/28/rgqbr490294065_1201039718244358_5594524229186926786_n.jpg

https://investorshub.advfn.com/uimage/upl
gedi8 gedi8 4 minutes ago
PR and 8-k out regarding the SEC notifying NXPL that they are not in compliance with the $1.00 listing price. Nxpl has180 days to come into compliance with this rule plus an additional 180 days if necessary.
NXPL
northam43 northam43 5 minutes ago
SPX Weekly Chart.

https://investorshub.advfn.com/uimage/uploads/2025/4/28/owvos1.1_Updates.PNG

https://investorshub.advfn.com/uimage/uploads/2025/4/28/nblynWeekly_Chart.png
StockInfo11 StockInfo11 5 minutes ago
Heliostar Metals (HSTR.v HSTXF) reported strong Q1 2025 results today with 9,082 Gold Eq oz produced, $27M cash, no debt, and costs below guidance. HSTR remains on track to meet 2025 gold production targets and is expanding drilling at La Colorada and Ana Paula. Full news:
https://www.heliost
HSTXF
StockInfo11 StockInfo11 6 minutes ago
This month, WRLG.v (WRLGF) advanced its H2 2025 gold production restart goals with bulk sample processing at Madsen and defined new gold targets at Rowan. Most recently, WRLG reinforced its commitment to worker safety today. Full news here⬇️
https://westredlakegold.com/news/

*P
WRLGF
Spillmonkey Spillmonkey 6 minutes ago
I’m very happy with where we stand now.
Metric ton production is going to be announced within weeks. We have backup capital. We are making strides in the lab to create better things.
Remember when the polartech announcement happened?
We are at the base of Everest. The share
KBLB
VikingDiviner97 VikingDiviner97 7 minutes ago
Surely you're not on this board looking out for the bulls livelihood right???
CGAC
k9narc k9narc 7 minutes ago
And he's a special kind of stupid.
jaramill jaramill 7 minutes ago
$HHSE-BLOG:..L.A. Major-Studio meetings-for-projects---including WILDFIRE-Distribution

Monday, March 17, 2025


(Click on link below to view photos/videos)


https://hannoverhousemovies.blogspot.com/2025/03/la-major-studio-meetings-for-projec
HHSE
VikingDiviner97 VikingDiviner97 7 minutes ago
Ur starting to sound desperate for a reason I can't think of 🤷‍♂️
CGAC
drumming4life drumming4life 8 minutes ago
Whoops…just caught a mistake. The last sentence of the 2nd paragraph should have read…
“ If you look at the Amazon case or any others, there are many AoS filed with the court by the SERVICE AGENT after serving the defendants.”
VPLM
Truenorth2016 Truenorth2016 8 minutes ago
SHEEPDOG did the same to me. Ahhh..... just like the gold ole days of Sprycel. He threatened me as being a paid basher and he was going to make me pay.

That was when the price was $.30 and the number of shares outstanding was less than 100K
GCAN
Investor2014 Investor2014 8 minutes ago
Taking that long is unlikely to be a good sign.
AVXL
williamssc williamssc 9 minutes ago
GBM is devastating unmet need. For what I've read their Vax trial demonstrated the ability to extend lives. I don't follow closely though.
AVXL
dennisdave dennisdave 9 minutes ago
I agree. But there is something else going on here. This whole understandable panic here is based on someone claiming that in the March MHRA minutes only 3 applications were backlogged. That is absolute bogus BS. Nothing in here https://assets.publishing.service.gov.uk/media/67f4d707c2fea2548f4eff58
NWBO
StockInfo11 StockInfo11 9 minutes ago
Black Swan Graphene (SWAN.v BSWGF) is scaling commercialization of its graphene-additive products for plastic and concrete enhancement, recently retaining DS Market Solutions to support share liquidity as it targets growth in major international markets💥
https://blackswangraphene.com/
BSWGF